Scott Haden Kollins
Professor in Psychiatry and Behavioral Sciences
Scott H. Kollins, PhD received his undergraduate degree in psychology from Duke and his Master’s and Doctorate degrees in Clinical Psychology from Auburn University. After completing his clinical internship at the University of Mississippi Medical Center, where he served as Chief Intern, he joined the faculty of the Department of Psychology at Western Michigan University for three years, before joining the Duke faculty in 2000. Dr. Kollins has published more than 125 scientific papers in peer-reviewed journals. Over the past 10 years, his research has been supported by 6 different federal agencies, including NICHD, NIDA, NIMH, NIEHS, NINDS, and EPA, and he currently holds a mid-career K24 award from NIDA. He has also served as PI on more than 40 industry-funded clinical trials and is a consultant to a number of pharmaceutical companies in the area of ADHD clinical psychopharmacology. He has served as a standing member of the Child Psychopathology and Developmental Disabilities study section and also served as an ad-hoc reviewer for 10 additional NIH study sections and 7 international granting agencies. He is an Associate Editor for the Journal of Attention Disorders and has reviewed for more than 50 different peer-reviewed journals. He is an elected member of the College on Problems of Drug Dependence and the American College of Neuropsychopharmacology. Dr. Kollins is a licensed clinical psychologist and maintains a practice through the ADHD Program’s outpatient clinic. His research interests are in the areas of psychopharmacology and the intersection of ADHD and substance abuse, particularly cigarette smoking.
Novel Approaches to Infant Screening for ASD in Pediatric Primary Care awarded by National Institutes of Health (Co Investigator). 2019 to 2024
Unified Program for Therapeutics in Children awarded by National Institutes of Health (Preceptor). 2019 to 2024
Scalable Computational Platform For Active Closed-Loop Behavioral Coding in Autism Spectrum Disorder awarded by National Institutes of Health (Consultant). 2019 to 2023
Duke CTSA (TL1) awarded by National Institutes of Health (Mentor). 2018 to 2023
Dyanavel Safety Study awarded by (Principal Investigator). 2019 to 2022
Mobile health interventions for varenicline adherence among HIV-positive smokers awarded by National Institutes of Health (Co-Mentor). 2017 to 2022
Dyanavel Efficacy Study awarded by (Principal Investigator). 2019 to 2021
Sleep Dysfunction and Neurocognitive Outcomes in Adolescent ADHD awarded by National Institutes of Health (Mentor). 2019 to 2021
Treating Pain in Fibromyalgia awarded by (Principal Investigator). 2020 to 2021
Maternal obesity, child executive functions and child weight gain awarded by National Institutes of Health (Principal Investigator). 2015 to 2021
Mitchell, J. T., and S. H. Kollins. “ADHD in adolescence.” Adolescent Health Psychology, edited by W. O’Donohue et al., Springer, 2013, pp. 423–45.
Mitchell, J. T., and S. H. Kollins. “Attention-deficit/hyperactivity disorder in adolescence.” Handbook of Adolescent Health Psychology, 2013, pp. 423–45. Scopus, doi:10.1007/978-1-4614-6633-8_27. Full Text
Kollins, S. H. “Abuse potential of stimulant drugs used to treat ADHD.” ADHD in Adults: Characterization, Diagnosis, and Treatment, 2011, pp. 230–39. Scopus, doi:10.1017/CBO9780511780752.020. Full Text
Fuemmeler, Bernard F., et al. “Associations between attention deficit hyperactivity disorder symptoms and eating behaviors in early childhood.” Pediatr Obes, vol. 15, no. 7, July 2020, p. e12631. Pubmed, doi:10.1111/ijpo.12631. Full Text
Kollins, Scott H., et al. “Increased subjective and reinforcing effects of initial nicotine exposure in young adults with attention deficit hyperactivity disorder (ADHD) compared to matched peers: results from an experimental model of first-time tobacco use.” Neuropsychopharmacology, vol. 45, no. 5, Apr. 2020, pp. 851–56. Pubmed, doi:10.1038/s41386-019-0581-7. Full Text
Kollins, S. H., et al. “A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial.” The Lancet Digital Health, vol. 2, no. 4, Apr. 2020, pp. e168–78. Scopus, doi:10.1016/S2589-7500(20)30017-0. Full Text
Childress, Ann C., et al. “Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder.” J Child Adolesc Psychopharmacol, vol. 30, no. 3, Apr. 2020, pp. 128–36. Pubmed, doi:10.1089/cap.2019.0117. Full Text
Childress, Ann C., et al. “Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Preschool Children with Attention-Deficit/Hyperactivity Disorder.” J Child Adolesc Psychopharmacol, vol. 30, no. 2, Mar. 2020, pp. 58–68. Pubmed, doi:10.1089/cap.2019.0085. Full Text
Kollins, Scott H. “Editorial: From risk prediction to action: leveraging electronic health records to improve pediatric population mental health.” J Child Psychol Psychiatry, vol. 61, no. 2, Feb. 2020, pp. 113–15. Pubmed, doi:10.1111/jcpp.13199. Full Text
Schechter, Julia, et al. “Effect of Prenatal Smoke Exposure on Birth Weight: The Moderating Role of Maternal Depressive Symptoms.” Nicotine Tob Res, vol. 22, no. 1, Jan. 2020, pp. 40–47. Pubmed, doi:10.1093/ntr/nty267. Full Text Open Access Copy
Lunsford-Avery, Jessica R., et al. “Sleep/Wake Regularity Associated with Default Mode Network Structure among Healthy Adolescents and Young Adults.” Sci Rep, vol. 10, no. 1, Jan. 2020, p. 509. Pubmed, doi:10.1038/s41598-019-57024-3. Full Text
Schrott, Rose, et al. “Cannabis use is associated with potentially heritable widespread changes in autism candidate gene DLGAP2 DNA methylation in sperm.” Epigenetics, vol. 15, no. 1–2, Jan. 2020, pp. 161–73. Pubmed, doi:10.1080/15592294.2019.1656158. Full Text
Mitchell, John T., et al. “Smoking abstinence effects on emotion dysregulation in adult cigarette smokers with and without attention-deficit/hyperactivity disorder.” Drug Alcohol Depend, vol. 205, Dec. 2019, p. 107594. Pubmed, doi:10.1016/j.drugalcdep.2019.107594. Full Text
Chen, S., et al. “A generic algorithm for sleep-wake cycle detection using unlabeled actigraphy data.” 2019 Ieee Embs International Conference on Biomedical and Health Informatics, Bhi 2019 Proceedings, 2019. Scopus, doi:10.1109/BHI.2019.8834568. Full Text
Lunsford-Avery, J. R., et al. “SLEEPING AT HOME: FEASIBILITY AND TOLERABILITY OF AMBULATORY POLYSOMNOGRAPHY FOR USE WITH ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER.” Sleep, vol. 41, OXFORD UNIV PRESS INC, 2018, pp. A283–84.
Murphy, S. K., et al. “Environment and Gametic Epigenetic Reprogramming.” Environmental and Molecular Mutagenesis, vol. 58, WILEY, 2017, pp. S28–S28.
McClernon, Francis J., et al. “COMBINED EMA AND GPS FOR ASSESSING THE SPATIAL DISTRIBUTION OF SMOKING BEHAVIOR: A PROOF OF CONCEPT STUDY.” Annals of Behavioral Medicine, vol. 45, SPRINGER, 2013, pp. S93–S93.
Bidwell, L. Cinnamon, et al. “Genotype and ADHD symptoms interact to predict adolescents' early smoking experiences in an epidemiological sample.” Behavior Genetics, vol. 41, no. 6, SPRINGER, 2011, pp. 893–893.
Witt, K. L., et al. “Chromosomal aberrations, sister chromatid exchanges, and micronuclei in lymphocytes of pediatric ADHD patients treated with stimulant drugs.” Environmental and Molecular Mutagenesis, vol. 49, no. 7, WILEY-BLACKWELL, 2008, pp. 528–528.
Goodman, D., et al. “Efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.” International Journal of Neuropsychopharmacology, vol. 11, CAMBRIDGE UNIV PRESS, 2008, pp. 292–93.
Kollins, Scott H., et al. “Cognitive and sedative effects of guanfacine extended release in children and adolescents aged 6 to 17 years with attention-deficit/hyperactivity disorder: Safety and sleep effects.” Biological Psychiatry, vol. 63, no. 7, ELSEVIER SCIENCE INC, 2008, pp. 246S-246S.
Kollins, Scott, et al. “Genetic associations with reaction time variability in AD/HD.” American Journal of Medical Genetics Part B Neuropsychiatric Genetics, vol. 141B, no. 7, WILEY-LISS, 2006, pp. 771–72.
Schug, M. D., et al. “The genetics of AD/HD: Subtyping, comorbidity and developmental considerations.” American Journal of Medical Genetics Part B Neuropsychiatric Genetics, vol. 130B, no. 1, WILEY-LISS, 2004, pp. 103–103.